UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Annals of oncology, 2014-09, Vol.25 (9), p.1729-1735

2014

Volltextzugriff (PDF)

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Annals of oncology, 2022-08, Vol.33 (8), p.750-768

2022

Volltextzugriff (PDF)

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Annals of oncology, 2017-08, Vol.28 (8), p.1996-2001

2017

Volltextzugriff (PDF)

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Annals of oncology, 2012-03, Vol.23 (3), p.618-624

2012

Volltextzugriff (PDF)

Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?

European journal of surgical oncology, 2017-05, Vol.43 (5), p.949-962

2017

Volltextzugriff (PDF)

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

Annals of oncology, 2010-09, Vol.21 (9), p.1765-1771

2010

Volltextzugriff (PDF)

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

Annals of oncology, 2013-08, Vol.24 (8), p.2057-2061

2013

Volltextzugriff (PDF)

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

Annals of oncology, 2010-04, Vol.21 (4), p.729-733

2010

Volltextzugriff (PDF)

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer

Annals of oncology, 2022-08, Vol.33 (8), p.769-785

2022

Volltextzugriff (PDF)

A covariate‐specific time‐dependent receiver operating characteristic curve for correlated survival data

Statistics in medicine, 2020-08, Vol.39 (19), p.2477-2489

2020

Volltextzugriff (PDF)

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

British journal of cancer, 2024-09, Vol.131 (4), p.702-708

2024

Volltextzugriff (PDF)

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Annals of oncology, 2013-05, Vol.24 (5), p.1231-1238

2013

Volltextzugriff (PDF)

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

Annals of oncology, 2008-03, Vol.19 (3), p.496-500

2008

Volltextzugriff (PDF)

Circulating tumor DNA detection in hepatocellular carcinoma

Annals of oncology, 2018-05, Vol.29 (5), p.1094-1096

2018

Volltextzugriff (PDF)

Circulating tumor cell count and thrombosis in metastatic breast cancer

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1981-1988

2017

Volltextzugriff (PDF)

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Oncogene, 2023-06, Vol.42 (23), p.1951-1956

2023

Volltextzugriff (PDF)

Survival of breast cancer patients with meningeal carcinomatosis

Annals of oncology, 2010-11, Vol.21 (11), p.2183-2187

2010

Volltextzugriff (PDF)

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial

Annals of oncology, 2013-12, Vol.24 (12), p.2999-3004

2013

Volltextzugriff (PDF)

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

ESMO open, 2021-06, Vol.6 (3), p.100154, Article 100154

2021

Volltextzugriff (PDF)

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Oncogene, 2023-04, Vol.42 (17), p.1417-1417

2023

Volltextzugriff (PDF)

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

Annals of oncology, 2008-07, Vol.19 (7), p.1261-1265

2008

Volltextzugriff (PDF)

Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial

Cancer letters, 2015-05, Vol.360 (2), p.213-218

2015

Volltextzugriff (PDF)

Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785]

Annals of oncology, 2023-03, Vol.34 (3), p.326-326

2023

Volltextzugriff (PDF)

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Annals of oncology, 2009-06, Vol.20 (6), p.1042-1047

2009

Volltextzugriff (PDF)

1 – 25 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(287)

Publikationsform

Sprache

Englisch
(238)
Französisch
(95)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer

A covariate‐specific time‐dependent receiver operating characteristic curve for correlated survival data

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

Circulating tumor DNA detection in hepatocellular carcinoma

Circulating tumor cell count and thrombosis in metastatic breast cancer

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

Survival of breast cancer patients with meningeal carcinomatosis

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial

Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785]

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Suchergebnisse filtern